Targeting DDX3X Triggers Antitumor Immunity via a dsRNA-Mediated Tumor-Intrinsic Type I Interferon Response. Choi H, Kwon J, Cho MS, Sun Y, et al. Cancer Res 2021;81:3607-3620.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Choi H, Kwon J, Cho MS, Sun Y, et al. Targeting DDX3X Triggers Antitumor Immunity via a dsRNA-Mediated Tumor-Intrinsic Type I Interferon Response. Cancer Res 2021;81:3607-3620.
PMID: 33941613